Choosing the right strategy for the management of patients with relapsed CLL
7 February 2019 — 12:20 PM CET

Choosing the right strategy for the management of patients with relapsed CLL

Live from the HME Debate in Madrid

Chair: John Gribben

 

Current and future options - Carol Moreno
Practical management/optimising outcomes - George Follows

 

After participating in this broadcast you should be able to: 
- Discuss recent clinical data relating to the management of patients with relapsed/refractory CLL.

more info...

A focus on B-cell lymphoma: What are the implications of the ASH 2018 updates for clinical practice?
7 February 2019 — 3:00 PM CET

A focus on B-cell lymphoma: What are the implications of the ASH 2018 updates for clinical practice?

Live from the HME Debate in Madrid

Chair: John Gribben

 

Key trends and updates from ASH 2018 for B-cell lymphomas - Christian Buske
Update on mantle cell lymphoma - Simon Rule
Update on Waldenström's macroglobulinemia - Steven Treon

 

After participating in this broadcast you should be able to:
- Identify how recent clinical data relating to B-cell lymphomas could potentially impact daily clinical practice.

more info...

The development of chimeric antigen receptor (CAR) T cells and their potential role in the treatment of haematological malignancies
7 February 2019 — 6:00 PM CET

The development of chimeric antigen receptor (CAR) T cells and their potential role in the treatment of haematological malignancies

Live from the HME Debate in Madrid

Chairs: John Gribben and Jesús San Miguel

 

After participating in this broadcast you should be able to:
- Describe the current and potential future role of CAR T cells in the management of a range of haematological malignancies.

more info...